Aiqin R. Gao

105 Jiefang Road
Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Chemoimmunotherapy improves surgical resection rate and survival versus chemotherapy in potentially resectable non-small cell lung cancer: a real-world propensity score-matched study.

Chemoimmunotherapy improves surgical resection rate and survival versus chemotherapy in potentially resectable non-small cell lung cancer: a real-world propensity score-matched study.

Journal: Journal of thoracic disease

Published: March 04, 2026

Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinoma.

Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinoma.

Journal: Journal of cancer research and clinical oncology

Published: December 31, 2025

Targeting ILT4 to Improve Immunotherapy Efficacy in Solid Tumour: From Bench to Bedside.

Targeting ILT4 to Improve Immunotherapy Efficacy in Solid Tumour: From Bench to Bedside.

Journal: ImmunoTargets and therapy

Published: June 18, 2025

Optimization of First-Line Treatment Options in HER2-Altered Lung Adenocarcinoma: A Real-World Study.

Optimization of First-Line Treatment Options in HER2-Altered Lung Adenocarcinoma: A Real-World Study.

Journal: Cancer medicine

Published: March 14, 2025

Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC.

Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC.

Journal: BMC pulmonary medicine

Published: March 01, 2025

Targeted combination chemotherapy effective in nuclear protein in testis carcinoma of lung origin: A case report and review of the literature.

Targeted combination chemotherapy effective in nuclear protein in testis carcinoma of lung origin: A case report and review of the literature.

Journal: Medicine

Published: February 19, 2025

Prognostic impact of the timing of immunotherapy in first-line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score-matched analysis.

Prognostic impact of the timing of immunotherapy in first-line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score-matched analysis.

Journal: International journal of cancer

Published: September 28, 2024

CT and MRI findings of intraorbital wooden foreign bodies.

CT and MRI findings of intraorbital wooden foreign bodies.

Journal: Clinical radiology

Published: August 23, 2024

Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer.

Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer.

Journal: BMC cancer

Published: August 16, 2024

Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma.

Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma.

Journal: Translational oncology

Published: August 11, 2024

Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial.

Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial.

Journal: EClinicalMedicine

Published: April 18, 2024

Immunoglobulin-like transcript 5 polarizes M2-like tumor-associated macrophages for immunosuppression in non-small cell lung cancer.

Immunoglobulin-like transcript 5 polarizes M2-like tumor-associated macrophages for immunosuppression in non-small cell lung cancer.

Journal: International journal of cancer

Published: February 20, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026